Johnson & Johnson
JNJ (NYSE)
Johnson & Johnson (JNJ) stands out as a defensive healthcare stock, making it an ideal choice for novice investors. With a solid dividend yield of 2.00% and impressive returns of 58.46% over the past year, it offers stability and consistent payouts. Analysts have a favorable outlook, with a median price target of $272.00 and a strong B+ rating, highlighting its diversified healthcare exposure and lower volatility compared to growth stocks.
Pros:
- Strong historical returns over 1 and 5 years
- Defensive healthcare stock with lower volatility
Cons:
- Market volatility risk
- Potential for lower growth compared to tech stocks
Johnson & Johnson (JNJ) may be suitable for conservative investors seeking a stable income through dividends, as well as those looking for a resilient stock in the healthcare sector. With its solid historical performance and lower volatility, it could serve as a reliable addition to a diversified portfolio, particularly for novice investors.